The ASEAN and North Asian Point of Care/Rapid Diagnostics Industry is Expected to Reach $3.9 Billion by 2026
December 14, 2021 11:13 ET
|
Research and Markets
Dublin, Dec. 14, 2021 (GLOBE NEWSWIRE) -- The "ASEAN and North Asian Point of Care/Rapid Diagnostics Market by Product (Glucose Monitoring, COVID, HIV, STDs, HAIs, Influenza, Tropical &...
Global Point of Care Diagnostic Market (2021 to 2027) - The Field of COVID-19 POC Diagnostics is Rapidly Evolving
December 09, 2021 10:03 ET
|
Research and Markets
Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Point of Care Diagnostic Market Size, Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" report has been...
Global COVID-19 Rapid Test Kits Markets Report 2021: Rapid Antigen, Rapid Antibody, Equipment and Extraction Kits, RT-PCR Test Kits, Reagents
December 09, 2021 03:38 ET
|
Research and Markets
Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Rapid Test Kits Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's...
World Immunoassay Market Strategies and Trends Report 2022 to 2026: Immunoassay vs. PCR vs. Sequencing - A See-Saw Battle
November 25, 2021 04:18 ET
|
Research and Markets
Dublin, Nov. 25, 2021 (GLOBE NEWSWIRE) -- The "Immunoassay Market: Strategies and Trends, Forecasts by Application, Technology, Product, User and by Country, with Multiplex and Point of Care Market...
Global Immunoassay Markets Report 2021-2025: Strategies, Trends & Forecasts by Instrument Type, Application with Multiplex and Point of Care Market Analysis
October 07, 2021 03:23 ET
|
Research and Markets
Dublin, Oct. 07, 2021 (GLOBE NEWSWIRE) -- The "Immunoassay Markets Strategies and Trends 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. The workhorse of the diagnostic...
Zyomyx Receives $7.5 Million From UNITAID to Launch Rapid, Service-Free Point-of-Care CD4 Test
March 26, 2014 07:30 ET
|
Zyomyx
FREMONT, Calif., March 26, 2014 (GLOBE NEWSWIRE) -- Zyomyx, Inc. has been awarded US$7.5 million from UNITAID to commercialize its quantitative MyT4™ point-of-care CD4 test, designed to guide...
Zyomyx Receives CE Mark for Its New MyT4(TM) Point-of-Care CD4 Test
January 09, 2014 07:30 ET
|
Zyomyx
FREMONT, Calif., Jan. 9, 2014 (GLOBE NEWSWIRE) -- Zyomyx, Inc., a provider of innovative point-of-care diagnostic tests, announced today that it received the CE Mark for its MyT4™ point-of-care...